{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:44:32Z","timestamp":1793357072473,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.yrtph.2019.104417","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T15:07:05Z","timestamp":1562080025000},"page":"104417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Next tier in vitro and in vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rate"],"prefix":"10.1016","volume":"107","author":[{"given":"Richard B.","family":"Dorshow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Bugaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yrtph.2019.104417_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yrtph.2015.02.018","article-title":"Pre-clinical toxicity evaluation of MB-102, a novel fluorescent tracer agent for real-time measurement of glomerular filtration rate","volume":"72","author":"Bugaj","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104417_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/jm070842+","article-title":"Fluorescence-enhanced europium-diethylenetriaminepentaacetic (DTPA)-monoamide complexes for the assessment of renal function","volume":"51","author":"Chinen","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2019.104417_bib3","first-page":"259A","article-title":"Initial clinical trial results of a real-time point-of-care glomerular filtration rate measurement utilizing a novel fluorescent tracer agent","volume":"26","author":"Dorshow","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yrtph.2019.104417_bib4","first-page":"597","article-title":"Clinical study results of a real-time point-of-care glomerular filtration rate measurement","volume":"28","author":"Dorshow","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yrtph.2019.104417_bib5","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00448.2010","article-title":"Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI)","volume":"301","author":"Endre","year":"2011","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.yrtph.2019.104417_bib6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1373\/clinchem.2011.167494","article-title":"Established and emerging markers of kidney function","volume":"58","author":"Ferguson","year":"2012","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.yrtph.2019.104417_bib7","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.yrtph.2019.104417_bib8","series-title":"Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use","author":"ICH S2(R1)","year":"2011"},{"key":"10.1016\/j.yrtph.2019.104417_bib9","series-title":"Photosafety Evaluation of Pharmaceuticals","author":"ICH Harmonised Tripartite Guideline S10","year":"2013"},{"key":"10.1016\/j.yrtph.2019.104417_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2019.104417_bib11","series-title":"Nonparametrics: Statistical Methods Based on Ranks, Chapter 1","author":"Lehmann","year":"1975"},{"key":"10.1016\/j.yrtph.2019.104417_bib12","series-title":"\u201cStatistical Evaluation of Mutagenicity Test Data\u201d (UKEMS Sub-committee on Guidelines for Mutagenicity Testing. Report Part III)","first-page":"184","article-title":"Statistical analysis of in vivo cytogenetic assays","author":"Lovell","year":"1989"},{"key":"10.1016\/j.yrtph.2019.104417_bib13","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yrtph.2019.104417_bib14","series-title":"\u201cGenetic Toxicity: Mammalian Erythrocyte Mocronucleus Test.\u201d in OECD Guidelines for the Testing of Chemicals","author":"OCED","year":"2014"},{"key":"10.1016\/j.yrtph.2019.104417_bib15","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.bmc.2012.03.015","article-title":"Exogenous fluorescent tracer agents based on pegylated pyrazine dyes for real-time point-of-care measurement of glomerular filtration rate","volume":"20","author":"Poreddy","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.yrtph.2019.104417_bib16","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1364\/AO.44.005956","article-title":"Optical, real-time monitoring of the glomerular filtration rate","volume":"44","author":"Rabito","year":"2005","journal-title":"Appl. Opt."},{"key":"10.1016\/j.yrtph.2019.104417_bib17","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1021\/jm200257k","article-title":"Hydrophilic pyrazine dyes as exogenous fluorescent tracer agents for real-time point-of-care measurement of glomerular filtration rate","volume":"54","author":"Rajagopalan","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2019.104417_bib18","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/ndt\/gfp225","article-title":"Transcutaneous measurement of glomerular filtration rate using FITC-sinistrin in rats","volume":"24","author":"Schock-Kusch","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yrtph.2019.104417_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","article-title":"Measuring GFR: a systematic review","volume":"64","author":"Soveri","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yrtph.2019.104417_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1383-5718(98)00175-2","article-title":"Rapid method for improving slide quality in the bone marrow micronucleus assay; an adapted cellulose column procedure","volume":"439","author":"Sun","year":"1999","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2019.104417_bib21","doi-asserted-by":"crossref","first-page":"F1873","DOI":"10.1152\/ajprenal.00218.2006","article-title":"Rapid determination of renal filtration function using an optical ratiometric imaging approach","volume":"292","author":"Yu","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019301813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019301813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:28:39Z","timestamp":1759494519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019301813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":21,"alternative-id":["S0273230019301813"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104417","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next tier in vitro and in vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rate","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104417"}}